Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)
- Conditions
- Major Depression in Remission
- Interventions
- Device: Aversive stimuli
- Registration Number
- NCT04325529
- Lead Sponsor
- Mclean Hospital
- Brief Summary
This study investigates how remitted individuals with past major depressive disorder (MDD) make approach-avoidance decisions and which brain regions are implicated in such decisions. Information collected through MRI and behavioral tasks will be used to predict depressive symptoms in the future.
- Detailed Description
The overarching goals of this research are to investigate: (1) neural substrates of approach/avoidance behaviors in remitted MDDs; (2) stress-induced signaling in remitted individuals with past MDD; (3) neural markers that prospectively predict disease course.
This will be achieved through an innovative method of using functional magnetic resonance imaging (fMRI) during an approach/avoidance decision-making task.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 148
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Control subjects Aversive stimuli healthy control subjects remitted MDD Aversive stimuli Unmedicated Remitted Participants with Past History of MDD
- Primary Outcome Measures
Name Time Method Clinical Interview Baseline For assessing psychological state
Salivary Cortisol Baseline For assessing stress level
MRI Data MRI scans take place within 30 days of Screening Visit For testing the neural correlates of approach-avoidance decision making behaviors in a trans-diagnostic sample
Follow-up Clinical interviews Change from Baseline at 6 months and 12 months after the MRI scanning visit To assess psychological state changes
Behavioral Performance on the Probabilistic Reward Task (PRT) Baseline The Probablilistic Reward Task assesses positive reinforcement learning.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
McLean Hospital
🇺🇸Belmont, Massachusetts, United States